LASW1393   Click here for help

GtoPdb Ligand ID: 10527

Synonyms: compound 34 [PMID: 31609613] | LASW-1393
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: LASW1393 is a pan-JAK inhibitor that was developed as an inhalation anti-inflammatory [1]. It is active in vivo in a rat model of airway inflammation.
PubChem CID 71062030 represents the compound without specified stereochemistry.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 4
Topological polar surface area 132.25
Molecular weight 365.16
XLogP 1.34
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#CCC1CCC(CC1)n1c(=O)[nH]c2c1nc(nc2)Nc1ccc[nH]c1=O
Isomeric SMILES N#CC[C@@H]1CC[C@H](CC1)n1c(=O)[nH]c2c1nc(nc2)Nc1ccc[nH]c1=O
InChI InChI=1S/C18H19N7O2/c19-8-7-11-3-5-12(6-4-11)25-15-14(23-18(25)27)10-21-17(24-15)22-13-2-1-9-20-16(13)26/h1-2,9-12H,3-7H2,(H,20,26)(H,23,27)(H,21,22,24)/t11-,12-
InChI Key NIIBPFADTOPKBI-HAQNSBGRSA-N
Immunopharmacology Comments
LASW1393 is a pan-JAK inhibitor that was developed as an inhalation anti-inflammatory for the treatment of respiratory diseases [1]. It exhibits good kinase selectivity, has a long lung retention time and low systemic exposure. LASW1393 reduces LPS-induced airway inflammation in a rat model when delivered via the inhaled route.